Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBP) Preferred Shares (2016 - 2025)

Regen BioPharma (RGBP) has disclosed Preferred Shares for 10 consecutive years, with $1011.0 as the latest value for Q4 2025.

  • On a quarterly basis, Preferred Shares changed 0.0% to $1011.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1011.0, a 0.0% change, with the full-year FY2025 number at $3.0, down 99.7% from a year prior.
  • Preferred Shares was $1011.0 for Q4 2025 at Regen BioPharma, up from $3.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $43929.0 in Q4 2021 to a low of $1.0 in Q2 2021.
  • A 5-year average of $5705.2 and a median of $526.5 in 2024 define the central range for Preferred Shares.
  • Biggest YoY gain for Preferred Shares was 439900.0% in 2022; the steepest drop was 99.99% in 2022.
  • Regen BioPharma's Preferred Shares stood at $43929.0 in 2021, then plummeted by 89.98% to $4400.0 in 2022, then crashed by 99.93% to $3.0 in 2023, then soared by 33600.0% to $1011.0 in 2024, then changed by 0.0% to $1011.0 in 2025.
  • Per Business Quant, the three most recent readings for RGBP's Preferred Shares are $1011.0 (Q4 2025), $3.0 (Q3 2025), and $3.0 (Q2 2025).